Presentation TVT 2021 Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis Presenter: John Forrest July 20, 2021
News Daily News Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest Caitlin E. Cox July 19, 2021
News Daily News Be ‘Mindful’ of TAVI Unknowns in Younger Patients, Experts Urge Caitlin E. Cox June 09, 2021
News Conference News EuroPCR 2021 Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI Yael L. Maxwell May 19, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Daily News TAVI Beneficial Even in Eldest Patients, Registry Reaffirms Caitlin E. Cox April 19, 2021
News Conference News CRT 2021 LRT Trial Data Bolster Support for TAVI in Bicuspid Valves L.A. McKeown March 11, 2021
News Daily News Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients Yael L. Maxwell March 02, 2021
News Daily News Beyond Research, KCCQ Scores Can Help Predict Events Post-TAVI/TMVR Yael L. Maxwell February 25, 2021
News Daily News Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution L.A. McKeown January 22, 2021
News Daily News TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis Yael L. Maxwell January 22, 2021
News Daily News Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk Todd Neale January 20, 2021
News Daily News Unplanned PCI Rare After TAVI, but Operators Get Good Results Michael O'Riordan January 18, 2021
News Daily News New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR Caitlin E. Cox December 23, 2020
News Conference News PCR London Valves 2020 No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION Shelley Wood November 26, 2020
News Daily News US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends Caitlin E. Cox November 17, 2020
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020